Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Puretech Health Plc ADR (NQ: PRTC ) 22.27 UNCHANGED Streaming Delayed Price Updated: 11:08 AM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Puretech Health Plc ADR < Previous 1 2 3 4 5 6 7 Next > PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro November 18, 2021 From PureTech Health plc Via Business Wire PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates November 16, 2021 From PureTech Health plc Via Business Wire PureTech Announces Participation in Two Upcoming Investor Conferences November 15, 2021 From PureTech Health plc Via Business Wire PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting November 12, 2021 From PureTech Health plc Via Business Wire PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer November 11, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China November 09, 2021 From PureTech Health plc Via Business Wire PureTech Announces Participation at the Jefferies London Healthcare Conference November 09, 2021 From PureTech Health plc Via Business Wire PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage November 01, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary October 14, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA October 05, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being October 05, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan September 29, 2021 From PureTech Health plc Via Business Wire PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance September 20, 2021 From PureTech Health plc Via Business Wire PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit September 14, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia September 10, 2021 From PureTech Health plc Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session August 30, 2021 Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of... Via Benzinga Earnings Scheduled For August 24, 2021 August 24, 2021 Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is... Via Benzinga PureTech Health plc – Half-Year Report August 24, 2021 From PureTech Health plc Via Business Wire PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021 August 23, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments August 17, 2021 From PureTech Health plc Via Business Wire PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer August 13, 2021 From PureTech Health plc Via Business Wire Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition August 11, 2021 Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107... Via Benzinga PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome August 11, 2021 From PureTech Health plc Via Business Wire PureTech: Notice of Half-Yearly Results August 03, 2021 From PureTech Health plc Via Business Wire The Week In SPAC News - Sunday, July 25 July 25, 2021 In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled. Via Talk Markets PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD July 22, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing July 21, 2021 From PureTech Health plc Via Business Wire PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp. July 19, 2021 From PureTech Health plc Via Business Wire 12 Health Care Stocks Moving In Thursday's Intraday Session July 15, 2021 Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 8.03% to $30.0 during Thursday's regular session. The current volume of 180.7K shares is 71.9% of Nkarta's... Via Benzinga PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) July 09, 2021 From PureTech Health plc Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.